Abbott Toxicology Alere Toxicology Icassette Dx (Pipette)

Yes, the Abbott Toxicology Icassette Dx is configured for reliable and highly sensitive Fentanyl (FTY/FYL) detection, making it suitable for professional diagnostic use.

Its reliability and utility are supported by these key features:

• Ultra-Sensitive Cutoff: The test is designed with an extremely low threshold of 1 ng/ml for Fentanyl, which ensures the high sensitivity required for accurate toxicology screening.
• CLIA Waived Status: This designation confirms the test meets the standards for simple, reliable usage in waived testing settings, simplifying regulatory compliance for point-of-care facilities.
• Targeted Immunoassay: This specific configuration is a single cassette dedicated solely to Fentanyl detection, minimizing potential cross-reactivity concerns.
• Factory New: Supplied as factory new stock from Abbott Toxicology, ensuring consistent quality and intended performance.

Each box of the Abbott Toxicology Icassette Dx contains 25 test cassettes. This packaging quantity is designed to support high-volume or point-of-care testing environments. These single-use cassettes are CLIA Waived and configured for the sensitive detection of Fentanyl (FTY/FYL) at a cutoff of 1 ng/ml.

This diagnostic cassette features a highly specific Fentanyl (FTY/FYL) Single Cassette configuration.

Key specifications related to its detection and compliance include:

• The optimized detection cut-off level for the Fentanyl assay is 1 ng/ml.
• The product is CLIA Waived, which streamlines regulatory compliance for use in various waived testing environments.
• Units are supplied as 25 factory-new cassettes per box, packaged for efficient, routine laboratory use.

Yes, this specific configuration of the Abbott Toxicology Icassette Dx for Fentanyl (FTY/FYL) detection is officially CLIA Waived.

This CLIA Waived status is a key benefit, as it signifies that the test meets standards for simple, reliable usage outside of complex laboratory environments.

It is ideal for:

• Point-of-care testing facilities.
• Environments seeking streamlined regulatory compliance for screening.

This cassette is configured to detect Fentanyl at a sensitive cutoff level of 1 ng/ml.

Yes, this configuration of the Abbott Toxicology Alere Toxicology Icassette Dx is specifically designed for Fentanyl (FTY/FYL) testing only. It is a highly targeted, single-analyte test.

This system offers reliability and ease of use:

• High Sensitivity: The cutoff concentration for detection is set at a highly sensitive 1 ng/ml.
• CLIA Waived Status: This designation simplifies regulatory compliance, making it suitable for use in waived testing environments such as point-of-care facilities.

The cassettes are supplied Factory New in boxes containing 25 units per box.

The Abbott Toxicology Alere Toxicology Icassette Dx is configured for highly sensitive qualitative immunoassay testing for Fentanyl (FTY/FYL).

• Detection Cutoff: 1 ng/ml

This specific low threshold ensures precise detection at minimal concentrations, which is essential for toxicology screening. Furthermore, the test holds CLIA Waived status, making it suitable for use in waived testing environments.

The Abbott Toxicology Alere Toxicology Icassette Dx (Pipette) is manufactured in the US.

Yes, the Abbott Toxicology Alere Toxicology Icassette Dx is designated as CLIA Waived.

This status is highly beneficial for professional diagnostic use as it indicates suitability for waived testing environments, simplifying regulatory compliance and allowing for use in point-of-care settings.

Key specifications for this cassette:

• Target Drug: Fentanyl (FTY/FYL)
• Cutoff Level: 1 ng/ml (high sensitivity)
• Packaging: Supplied in boxes of 25 cassettes

Each box of the Abbott Toxicology Alere Toxicology Icassette Dx contains 25 single Fentanyl (FTY/FYL) cassettes. This quantity is supplied as a pipette format component, optimized for convenience in high-volume, CLIA Waived testing environments.

Yes, this diagnostic cassette is designed for highly targeted screening.

It is a single-assay system specifically configured for the qualitative detection of Fentanyl (FTY/FYL) metabolites only. Key performance features include:

• Specific Target: Exclusively screens for Fentanyl.
• High Sensitivity: Operates at a precise cutoff concentration of 1 ng/ml, maximizing detection accuracy.
• CLIA Waived Status: Ensures suitability for reliable, simplified use in point-of-care and waived testing environments.